Company Short-Term Debts: Singular Genomics Systems (OMIC)

Singular Genomics Systems Inc (OMIC) - corporate logo

Singular Genomics Systems (OMIC) management aims to create advanced genome analysis systems to improve the accuracy of medical diagnostics. The company's operational processes are strictly regulated by FDA standards, particularly regarding biohazardous waste processing. The business relies on the competitive advantages of the G4 platform, which provides ultra-fast sequencing, with the indicator standing at 0.01. The price trend below illustrates the dynamics of the issuer's specific short-term debt.

singulargenomics.com (OMIC) Company Short-Term Indebtedness: for the period 07/04/2022 - 03/01/2025

Singular Genomics Corp - analytical breakdowns and key metrics (OMIC)

- price and consensus price forecast:
Price Chart Singular Genomics|OMIC - Analyst Median Target
- market capitalization data:
Market Capitalization Singular Genomics Systems|OMIC - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Singular Genomics|OMIC - Accounting Capitalization|Market Capitalization to Book Value Ratio singulargenomics.com|OMIC - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Equity Ratio Singular Genomics Systems|OMIC - Long-Term Debt to Capital|Short-Term Debt to Equity Singular Genomics Systems|OMIC - Company Debts|Debts to Book Capitalization Singular Genomics Systems|OMIC - Company Long-Term Debts|Company Short-Term Debt Singular Genomics
Analysis of all company metrics:Singular Genomics (OMIC)
Manufactured products of Singular Genomics Systems

For Singular Genomics Systems (OMIC), which updates lithography equipment in production cleanrooms, the amount of short-term financial debt reflects the ability to maintain operational stability during asset modernization. This indicator aggregates all liabilities with a maturity of up to one year, allowing investors to assess interest rate risks and the issuer's overall solvency during the interquarter period through liquidity dynamics.

Competitor analysis for Singular Genomics Systems

Company Short-Term Debt TEM (Tempus AI, Inc)|QGEN - Short-Term Debt Volume|Ionis Pharma - Company Short-Term Debts|RGEN (Repligen Inc.) - Short-Term Debt Volume|Company Short-Term Debt Avidity Biosciences (RNA)|Company Short-Term Indebtedness crisprtx.com|WGS: Company Short-Term Debts|Short-Term Indebtedness Ultragenyx Pharmaceutical Inc. RARE|Company Current Liabilities BEAM (Beam Therapeutics Corp)|Sarepta Corp - Company Short-Term Debts|TWST - Company Short-Term Debt|TXG - Company Short-Term Debt|NTLA: Company Short-Term Debts|STOK (Stoke Therapeutics Inc) - Company Short-Term Debts|BLFS - Company Short-Term Debt|Company Short-Term Loans and Borrowings Wave Pharma (WVE)|Maze Therapeutics Inc (MAZE) - Company Current Liabilities|Company Short-Term Loans and Borrowings sionnatx.com (SION)|PRME (Prime Medicine) - Company Short-Term Debts|Short-Term Indebtedness Taysha Gene Therapies Inc TSHA|QURE (uniQure Corp) - Company Short-Term Debts|MGTX: Short-Term Debt|Company Short-Term Debt REGENXBIO Inc.|SLDB (solidbio.com) - Company Short-Term Indebtedness|Company Short-Term Debt OCGN (Ocugen)|Short-Term Debt PACB|Company Short-Term Debt BNTC (Benitec)|Company Current Liabilities Design Corp (DSGN)|Company Short-Term Debts RCKT|Short-Term Debt Volume 4dmoleculartherapeutics.com FDMT|LXEO: Company Short-Term Debts|KRRO: Company Current Liabilities|Editas - Company Short-Term Debt|Short-Term Debt Volume Silence Therapeutics Corp|PRQR - Company Current Liabilities|Company Short-Term Loans and Borrowings CDXS|SGMO (Sangamo Therapeutics, Inc.) - Company Short-Term Debt|Short-Term Debt Volume nautilus.bio NAUT|MGX: Company Current Liabilities|precisionbiosciences.com - Short-Term Debt|Company Short-Term Debt GBIO (Generation Bio Corp)|boundlessbio.com (BOLD) - Short-Term Debt Volume|XCUR - Company Current Liabilities|Imunon (IMNN) - Amount of Current Liabilities|Company Short-Term Debts PHIO (Phio Pharmaceuticals Corp)|Short-Term Debt MBIO|Company Short-Term Debt RNAZ (TransCode Therapeutics)|Company Current Liabilities BNGO (bionanogenomics.com)|Company Short-Term Debt APDN|bluebird bio Inc. - Short-Term Debt Volume|IPA (ImmunoPrecise) - Company Short-Term Debt|OMGA: Short-Term Debt|RGLS (Regulus Therapeutics) - Company Short-Term Debt|syros.com (SYRS) - Company Current Liabilities|TBIO: Company Short-Term Debts|Short-Term Debt Volume TRACON Pharmaceuticals Inc.|Company Short-Term Debts UBX (Unity Bio)